Literature DB >> 11751497

Actual invasive potential of human hepatocellular carcinoma revealed by in situ gelatin zymography.

T Kaneyoshi1, H Nakatsukasa, T Higashi, K Fujiwara, I Naito, K Nouso, K Kariyama, Y Kobayashi, M Uemura, S I Nakamura, Y Iwasaki, T Tsuji.   

Abstract

BACKGROUND: The matrix-degrading proteinases are believed to play an important role in the invasion and metastasis of hepatocellular carcinoma (HCC), but no one has ever seen the in situ matrix-degrading activity in HCCs.
PURPOSE: To demonstrate the cellular localization of actual gelatinolytic activity and to investigate the invasive potential of human HCC. EXPERIMENTAL
DESIGN: HCC cases (30) were subjected to in situ gelatin zymography and SDS-gelatin gel zymogram.
RESULTS: In situ gelatin zymography revealed a heterogeneous gelatinolytic activity in HCC cells, as well as stromal cells of noncancerous livers. The gelatinolytic intensity was stronger in 15 HCC nodules than in the corresponding noncancerous livers and was significantly associated with the cancer invasion to the capsule of the HCCs and to the portal veins. An intense gelatinolytic activity was detected in HCC cells in the front of tumor invasion. SDS-gelatin gel zymogram revealed gelatinases A and B that were mostly in latent forms.
CONCLUSIONS: The present study demonstrates high gelatinolytic activity at the invasive front of HCCs at a cellular level and that HCC has an invasive potential with the gelatin (matrix)-degrading metalloproteinases. Furthermore, it suggests the importance of the activation mechanism of gelatinolytic enzymes in the invasion and metastasis of HCCs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751497

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  6 in total

1.  Mechanism of metastasis by membrane type 1-matrix metalloproteinase in hepatocellular carcinoma.

Authors:  Ying-Chi Ip; Siu-Tim Cheung; Ka-Ling Leung; Sheung-Tat Fan
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

Review 2.  Myeloid cells in hepatocellular carcinoma.

Authors:  Shanshan Wan; Ning Kuo; Ilona Kryczek; Weiping Zou; Theodore H Welling
Journal:  Hepatology       Date:  2015-07-01       Impact factor: 17.425

3.  Metalloproteinases 2 and 9 activity during promotion and progression stages of rat liver carcinogenesis.

Authors:  Kelly Silva Furtado; Paulo Wagner Pires; Luis Antonio Justulin; Maria Aparecida Marchesan Rodrigues; Sergio Luis Felisbino; Luis Fernando Barbisan
Journal:  J Mol Histol       Date:  2008-12-04       Impact factor: 2.611

Review 4.  MicroRNA-224: as a potential target for miR-based therapy of cancer.

Authors:  Wei Chen; Xue-Mei Fan; Ling Mao; Jun-Ying Zhang; Jian Li; Jian-Zhong Wu; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2015-08-08

5.  Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.

Authors:  Michael Zeisberg; Mona Khurana; Velidi H Rao; Dominic Cosgrove; Jean-Philippe Rougier; Michelle C Werner; Charles F Shield; Zena Werb; Raghu Kalluri
Journal:  PLoS Med       Date:  2006-03-07       Impact factor: 11.069

6.  Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).

Authors:  Kazuhiro Fukushima; Akinori Nakamura; Hideho Ueda; Katsutoshi Yuasa; Kunihiro Yoshida; Shin'ichi Takeda; Shu-ichi Ikeda
Journal:  BMC Musculoskelet Disord       Date:  2007-06-28       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.